HealthStream, Inc. (NASDAQ:HSTM - Get Free Report) has been given a consensus rating of "Moderate Buy" by the five research firms that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, two have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $31.50.
Several equities research analysts recently weighed in on the company. Craig Hallum upgraded HealthStream to a "strong-buy" rating in a research note on Thursday, October 17th. Barclays lifted their target price on HealthStream from $32.00 to $34.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 23rd. Canaccord Genuity Group raised their target price on shares of HealthStream from $28.00 to $29.00 and gave the stock a "hold" rating in a research report on Wednesday, October 23rd. Finally, StockNews.com downgraded HealthStream from a "strong-buy" rating to a "buy" rating in a research note on Wednesday, July 24th.
Get Our Latest Report on HSTM
Insider Buying and Selling
In other news, Director Tate Deborah Taylor sold 1,400 shares of the stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $28.53, for a total value of $39,942.00. Following the completion of the transaction, the director now owns 22,326 shares in the company, valued at $636,960.78. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, Director Tate Deborah Taylor sold 1,400 shares of the business's stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $28.53, for a total transaction of $39,942.00. Following the sale, the director now owns 22,326 shares of the company's stock, valued at $636,960.78. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Kevin P. O'hara sold 3,000 shares of HealthStream stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total value of $84,090.00. Following the transaction, the senior vice president now directly owns 9,527 shares of the company's stock, valued at approximately $267,041.81. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 20.60% of the stock is currently owned by corporate insiders.
Institutional Trading of HealthStream
Several large investors have recently modified their holdings of HSTM. Vanguard Group Inc. boosted its holdings in shares of HealthStream by 1.1% during the first quarter. Vanguard Group Inc. now owns 2,938,685 shares of the technology company's stock worth $78,345,000 after purchasing an additional 31,943 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of HealthStream by 1.0% in the second quarter. Dimensional Fund Advisors LP now owns 1,570,735 shares of the technology company's stock valued at $43,824,000 after buying an additional 15,379 shares in the last quarter. First Eagle Investment Management LLC grew its position in HealthStream by 7.1% in the second quarter. First Eagle Investment Management LLC now owns 530,178 shares of the technology company's stock valued at $14,792,000 after acquiring an additional 35,350 shares in the last quarter. Harbor Capital Advisors Inc. boosted its stake in shares of HealthStream by 141.2% in the third quarter. Harbor Capital Advisors Inc. now owns 400,033 shares of the technology company's stock valued at $11,537,000 after purchasing an additional 234,148 shares during the period. Finally, Assenagon Asset Management S.A. lifted its stake in shares of HealthStream by 37.3% in the third quarter. Assenagon Asset Management S.A. now owns 201,601 shares of the technology company's stock worth $5,814,000 after acquiring an additional 54,775 shares in the last quarter. 69.58% of the stock is currently owned by institutional investors and hedge funds.
HealthStream Stock Performance
Shares of NASDAQ HSTM traded up $0.03 during trading on Friday, reaching $29.27. The stock had a trading volume of 58,688 shares, compared to its average volume of 113,331. The company has a market cap of $890.39 million, a P/E ratio of 45.14, a PEG ratio of 3.89 and a beta of 0.36. The business's 50-day moving average price is $28.78 and its 200-day moving average price is $28.02. HealthStream has a fifty-two week low of $23.92 and a fifty-two week high of $31.15.
HealthStream (NASDAQ:HSTM - Get Free Report) last released its earnings results on Monday, October 21st. The technology company reported $0.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.13 by $0.06. The firm had revenue of $73.10 million during the quarter, compared to analyst estimates of $73.53 million. HealthStream had a return on equity of 5.67% and a net margin of 6.84%. HealthStream's revenue was up 4.0% compared to the same quarter last year. During the same period last year, the business posted $0.13 earnings per share. Analysts forecast that HealthStream will post 0.63 EPS for the current fiscal year.
HealthStream Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Monday, November 4th will be paid a dividend of $0.028 per share. This represents a $0.11 dividend on an annualized basis and a dividend yield of 0.38%. The ex-dividend date is Monday, November 4th. HealthStream's dividend payout ratio (DPR) is 16.92%.
About HealthStream
(
Get Free ReportHealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
Recommended Stories
Before you consider HealthStream, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthStream wasn't on the list.
While HealthStream currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.